AlloCure's Series A - II Round

AlloCure raised a round of funding on November 18, 2009.

AlloCure is a biotechnology company developing the use of cell therapy for the treatment of kidney disease. AlloCure's technology allows for the isolation and expansion of a specific population of mes…

Articles about AlloCure's Series A - II Round: